Business of Medicine
Commentary
The 2023 ‘Meddy’ awards
When did the best ‘is there a doctor in the house?’ moment occur in a motion picture?
Latest News
DEA proposals on telehealth for controlled substances draw fire
Both proposals would allow providers to prescribe a 30-day supply of a controlled substance or buprenorphine, but then require a face-to-face...
Commentary
Clinician violence: Virtual reality to the rescue?
Workplace violence is affecting so many providers in hospital emergency departments but also throughout other parts of the hospital.
Feature
Who can sue docs for wrongful death? Some states are trying to expand that group
Plus, the types of emotional damage that physicians can be sued for is expanding in pockets across the nation.
News from the FDA/CDC
FDA strengthens mammography regulations: Final rule
A final rule requires that mammography facilities notify patients about the density of their breasts.
Feature
Telehealth doctor indicted on health care fraud, opioid distribution charges
According to court documents, Dr. Sangita Patel was responsible for submitting Medicare claims for improper telehealth visits she didn’t conduct...
Commentary
What’s it like to take Ozempic? A doctor’s own story
‘With the rising popularity of weight loss drug injections, I’ve received many questions from patients about the pros, cons, and costs,” doctor...
Feature
New documentary highlights human toll of high insulin cost
The new film makes a broader case for overall prescription drug price reform in the United States.
Feature
Specialty and age may contribute to suicidal thoughts among physicians
“The specialties with the highest reporting of physician suicidal thoughts are also those with the greatest physician shortages.”
Feature
Popular book by USC oncologist pulled because of plagiarism
The Los Angeles Times reported earlier this week that it identified at least 95 instances of plagiarism by Dr. David B. Agus.
Latest News
HER2-low breast cancer is not a separate clinical entity: Study
Much attention has been focused recently on the idea that breast cancer with a low expression of HER2 can be treated with HER2-targeted agents,...